Hints and tips:
...Pharmaceutical company earnings Drugmaker Bristol-Myers Squibb is scheduled to report fourth-quarter results and is expected to post a higher profit than last year on increased sales of its cancer drugs...
...Bristol Myers Squibb was a rare gainer, its shares lifting 1.7 per cent to $21.02 after the US Food and Drug Administration said analyses of its experimental diabetes drug showed it met the agency’s guidelines...
International Edition